[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100542452":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":27,"locations":35,"responsibleParty":54,"collaborators":10,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":10,"enrollmentInfo":67,"targetDuration":10,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Icahn School of Medicine at Mount Sinai","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Fetal Growth Restriction diagnosed > 27w6d gestation",null,"Patients with a new diagnosis of fetal growth restriction after 27 weeks 6 days' gestation.",[13],"Device: USCOM",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","USCOM","Device that measures how much blood is being pumped in and out of the heart.",[9],[21,24],{"name":22,"affiliation":5,"role":23},"Nicola F Tavella, MPH","STUDY_DIRECTOR",{"name":25,"affiliation":5,"role":26},"Rachel J Meislin, MD","PRINCIPAL_INVESTIGATOR",[28,32],{"name":22,"role":29,"phone":30,"phoneExt":10,"email":31},"CONTACT","212-241-3888","nicola.tavella@mssm.edu",{"name":33,"role":29,"phone":10,"phoneExt":10,"email":34},"Allison Perelman, MD","allison.perelman@mssm.edu",[36],{"facility":37,"status":38,"city":39,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Mount Sinai Hospital","RECRUITING","New York","10029","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-74.00597,40.71427,{"lat":47,"lon":46},[50,52],{"name":22,"role":29,"phone":51,"phoneExt":10,"email":31},"2122413888",{"name":53,"role":26,"phone":10,"phoneExt":10,"email":10},"Rachel J Meislin",{"type":26,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Rachel Meislin","Assistant Professor","100542452","uscom-in-newly-diagnosed-fgr-cases-100542452",false,"NCT06343051","USCOM in Newly Diagnosed FGR Cases","Ultrasound Hemodynamic Assessment in Newly Diagnosed Fetal Growth Restriction: A Pilot Study","USCOM FGR","Inclusion Criteria:\n\n* Pregnant patients with a new diagnosis of fetal growth restriction (estimated fetal weight \\\u003C10th percentile or abdominal circumference \\\u003C10th percentile) in the third trimester (gestational age \\>27w6d)\n\nExclusion Criteria:\n\n* Multiple gestation\n* Fetal anomalies\n* Gestational diabetes or pregestational diabetes.","ALL","18 Years",{"count":68,"type":69},100,"ESTIMATED","OBSERVATIONAL","The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.",[73,17],"Fetal Growth Restriction","2025-02-06",{"date":76,"type":77},"2025-02-10","ACTUAL",{"date":79,"type":77},"2024-07-02",{"date":81,"type":69},"2026-06",{"name":5,"class":6},1]